欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0918/004
药品名称Numeta G13E
活性成分
    • alanine 4.66 g
    • arginine 4.89 g
    • aspartic acid 3.5 g
    • calcium chloride dihydrate 3.45 g
    • cysteine 1.1 g
    • glucose monohydrate 550.0 g
    • glutamic acid 5.83 g
    • glycine 2.33 g
    • histidine 2.21 g
    • isoleucine 3.9 g
    • leucine 5.83 g
    • lysine 6.41 g
    • MAGNESIUM ACETATE tetrahydrate 0.63 g
    • methionine 1.4 g
    • ornithine 1.45 g
    • phenylalanine 2.45 g
    • potassium acetate 3.83 g
    • proline 1.75 g
    • serine 2.33 g
    • sodium glycerophosphate hydrate 6.15 g
    • taurine 0.35 g
    • threonine 2.16 g
    • tryptophan 1.17 g
    • tyrosine 0.45 g
    • valine 4.43 g
剂型Emulsion for infusion
上市许可持有人Baxter Medical AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      Numeta G 13 % E
    • Denmark (DK)
      Numeta G13E
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Numeta G 13 % E Emulsion zur Infusion
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      NUMETA® PRETERM
    • Norway (NO)
      Numeta G13E
    • Finland (FI)
    • Poland (PL)
      NUMETA G13% E Preterm
    • Czechia (CZ)
      Numeta G13%E
    • Malta (MT)
    • Belgium (BE)
      Numetzah G13%E émulsion pour perfusion
许可日期2016/03/15
最近更新日期2024/01/16
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1：Line Extension
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase